Summary:
Chicago Research Center is conducting a phase 3, double blind, placebo and active-controlled study evaluating the effectiveness of an investigational medication for the treatment of fibromyalgia pain.
The study is 5 months and contains 13 visits.
Qualified Participants Must:
• Have or suspect you have Fibromyalgia
• Be 18 years of age or older
• Have no other significant health conditions
Qualified Participants May Receive:
All study related care and medicine at no cost. Qualified participants may receive compensation for time and travel.